In TRIUMPH-4, nausea reached up to 43% at the 12mg dose, and retatrutide introduced a dysesthesia (altered skin sensation) signal not seen with semaglutide or tirzepatide
BMI: body mass index, HbA1c: glycated hemoglobin, FPG: fasting plasma glucose, CGM: continuous glucose monitoring
Exercise especially vigorous exercise is one of the most powerful dopamine-boosting tools we have
The dosage chart presented here provides a framework, but the clinical nuances, specifically the titration pace, the dose ceiling, the choice of synergistic agents, and the biomarker monitoring schedule, should be individualized by a physician familiar with both the patient's metabolic history and the evolving evidence base for mitochondrial peptide therapy
This medication was approved by the FDA in November 2023 for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as hypertension, type 2 diabetes, or high cholesterol